The page is the record's research on the issuer — no analyst, no rating, no view. # CRISM THERAPEUTICS CORPORATION (AIM: CRTX) — research page As of 2026-11-06 · uk-cm-kg · record version 1 ## Identity and listing The issuer is CRISM THERAPEUTICS CORPORATION, listed on AIM under ticker CRTX, with ISIN VGG042401262 and LEI 213800XFW6MKVCHHPW88. Its security type is Corporate, its segment is ASQ1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is British Virgin Islands (VG). Its listing status is listed, not halted. ## The disclosure read The record holds 33 filings in the twelve months to 2026-11-06, across 30 filing days. The median gap between filing days is 8 days. The latest filing is dated 2026-11-02, is of type early_warning, and falls 4 days before the record date. On AIM the median cadence gap is 7.0 days, the median filings count is 33.5, and the median latency is 4 days across 594 issuers. In the sector the median cadence gap is 6.0 days, the median filings count is 42, and the median latency is 4.0 days across 51 issuers. By type the record holds 17 regulatory_announcement, 6 early_warning, 5 agm_record_date, 3 corporate_action, 1 ch_officer_change and 1 financial_statement filing. ## Auditor The auditor is not on the record, as none was found. The auditor's location is not on the record. Auditor changes are not on the record, because this register has no lifecycle type map yet (SHELF-01: us and ca first). ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, because this register has no lifecycle type map yet (SHELF-01: us and ca first). The halt flag is listed, not halted. ## Orderability For the elective professional client category the signal is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. For the eligible counterparty category the signal is not determinable, for the same reason. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The vintage is not sealed for this market. No issuer years are sealed. The market's earliest sealed date is not on the record. The live record began on 2026-09-11. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange) - https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/CRTX (identity.isin) - https://find-and-update.company-information.service.gov.uk/company/FC042176 (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://www.londonstockexchange.com/stock/CRTX/crism-therapeutics-corporation/company-page (identity.sector) - https://mcp.uk-cm-kg.ai/events/AIM/CRTX (the disclosure lines) - https://marketsecurities.fca.org.uk/officiallist (the halt flag) - https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.uk-cm-kg.ai/record/AIM/CRTX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/uk/AIM/CRTX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp